Safety and Exploratory Efficacy at 36 Months in Open-HART, an Open-Label Extension Study of Pridopidine in Huntington’s DiseaseAndrew McGarry, Michael R. Hayden, Spyridon Papapetropoulos et al.|Journal of Huntington s Disease|2017Cited by 18